222052-48-4

Upstream product

• 104-88-1 4-chlorobenzaldehyde 
• 617-35-6 2-oxo-propionic acid ethyl ester 
• 113-24-6 sodium pyruvate 
• 133678-11-2 ethyl 2-oxo-4-(p-chlorophenyl)but-3-enoate 

Downstream Products

• 33185-97-6 4-(4-chlorophenyl)-2-oxo-3-butenoic acid 
• 863034-64-4 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-1H-pyrazole-3-carboxylic acid 

Relevant academic research and scientific papers

SUBSTITUTED PYRIDINE COMPOUNDS AS PESTICIDES

The present invention relates to novel substituted pyridine compounds of the formula (I) in which R1, R2, R3, R4, R5, R6, V1, V2 and Q1 have the definitions

Substituted pyrazoline for preventing weight gain

The present invention relates to an active substance combination comprising at least one substituted pyrazoline compound and at least one drug, known to produce weight-gain as a side effect, a medicament comprising said active substance combination, a pharmaceutical formulation comprising said active substance combination and the use of said active substance combination for the manufacture of a medicament.

Combination of substituted pyrazolines and agent for treating dyslipidemia

The present invention relates to an active substance combination comprising at least one substituted pyrazoline compound and at least one lipid lowering compound used to treat dyslipidaemia, a medicament comprising said active substance combination, a pha

A-polymorph of a substituted pyrazoline, its preparation and use as medicaments

The present invention relates to the α-Polymorph of (rac)-N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4,5-dihydro-1H-pyrazole-3-carboxamide, methods for its preparation, medicaments comprising this compound as well as their use for the prepara

Use of substituted pyrazoline compounds for the treatment of coagulation related diseases

The present invention relates to the use of substituted pyrazoline compounds for the treatment of coagulation related diseases in humans and animals.

Use of substituted pyrazoline compounds and their derivatives for the treatment of cannabinoid system-associated diseases

The present invention relates to the use of substituted pyrazoline compounds, their derivatives as well as

SUBSTITUTED PYRAZOLINE COMPOUNDS: METHODS FOR THEIR PREPARATION

Methods for obtaining the substituted pyrazoline compounds of general formula (Ia) as well as the intermediates of general formula (III) to this compound. Thus 5-(R10,R11,R12-phenyl)-1-(R13,R14,R

Combination of a substituted pyrazoline compound and a drug used in food-related disorders

The present invention relates to an active substance combination comprising at least one substituted pyrazoline compound and at least one compound used in food-related disorders, a medicament comprising said active substance combination, a pharmaceutical

Combination of pyrazoline type cannabinoid receptor antagonist and statin

The present invention relates to an active substance combination comprising at least one substituted pyrazoline compound and at least one statin compound, a medicament comprising said active substance combination, a pharmaceutical formulation comprising s

Use of substitued pyrazoline compounds for the preparation of medicaments for the treatment of metabolic syndrome

The present invention relates to the use of substituted pyrazoline compounds for the manufacture of a medicament for the treatment of metabolic syndrome.